Yelong Shen1,2, Lirong Yan1, Xingfeng Shao1, Bin Zhao2, Jinlun Bai3, Wange Lu3, and Danny JJ Wang1
1Laboratory of FMRI Technology (LOFT), Mark & Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California (USC), Los Angeles, CA, United States, 2Shandong Medical Imaging Research Institute, School of Medicine, Shandong University, Jinan, China, 3Broad Stem Cell Institute, Keck School of Medicine, University of Southern California (USC), Los Angeles, CA, United States
Synopsis
This study aimed to investigate the feasibility and sensitivity of cellular
MRI with ferumoxytol nanocomplex labeled macrophages at ultrahigh magnetic
field of 7T. Different labeling strategies, labeling times, magnetic field
strengths, imaging sequences and post processing methods were evaluated to
achieve the optimal protocol. Combining ferumoxytol, heparin and protamine (HFP
nanocomplex) labeled macrophages with balanced steady-state
free precession (bSSFP) sequence on a 7T MRI scanner and post
processed by root mean square (RMS) combination of multiple phases
showed the best contrast in phantom and ex vivo experiments, reaching a
sensitivity for detecting a few tens of cells.
Introduction
Cellular
MRI is a growing field to detect, track, and quantify cells that allows for
studying cellular events related to disease processes and may be used as a
biomarker of intervention
1. Super-paramagnetic iron oxide nanoparticles
(SPIO) are the most common approach to label cells. However, the sensitivity is
relatively low with a detection limit on the order of thousands of cells. The
purpose of this study was to investigate the feasibility and sensitivity of cellular
MRI with ferumoxytol (Feraheme, AMAG Pharmaceuticals) nanocomplex labeled
macrophages at ultrahigh magnetic field of 7T.
Methods
Self-assembling nanocomplexes by combining ferumoxytol, heparin and
protamine (HFP) was introduced recently for efficient cell labeling and strong
T2 relaxivity 2. THP-1 cells that are
a human promonocytic cell line derived from acute monocytic leukemia were
maintained at 37°C and incubated for 3 days to convert THP-1
cells into a phagocytic macrophage cell line. Different labeling strategies
and labeling times were tested on the THP-1 induced macrophages (Fig. 1),
including 1) ferumoxytol only; 2) ferumoxytol + protamine; and 3) ferumoxytol
+ heparin + protamine (HFP nanocomplex)2 which were used to
label the cells for two days. The labeled cells were injected into a double
layer of gelatin phantom visible to both microscope and MRI (Fig. 2). All MR images
were acquired on a 3T Prisma and 7T Terra system (Siemens, Erlangen, Germany)
with 32-channel head coils. Different MRI pulse sequences using susceptibility
weighted imaging (SWI) and balanced steady-state free precession (bSSFP) were
applied with the following parameters: FOV=100mm, resolution=0.2×0.2×0.2mm3,
for 3T TR=32ms/12ms, TE=20ms/6ms and FA=15°/50°, measurement time=10.43min/2.05min
for each average of SWI and bSSFP respectively; for 7T TR=25ms/9ms, TE=13ms/5ms
and FA=15°/40°, measurement time= 8.33min/1.58min for each average of SWI and
bSSFP respectively). To minimize the banding-artifact in bSSFP, phase cycling
was performed with a total step of 16. The average (AVE), maximum intensity
projection (MIP) and root mean square (RMS) images were generated for the
phase-cycled bSSFP images using a custom MATLAB program. Contrast to noise
ratio (CNR) was calculated. Image co-registration between
microscope and MRI was performed using bspline transformation and mutual information
metric provided in Elastix 3. Ex vivo experiments
were then performed using a Formalin fixed pig brain injected with ~100 and
~1000 labeled cells respectively.Results
As shown in Fig. 1, self-assembling nanocomplexes by combining
ferumoxytol, heparin and protamine show much higher labeling efficiency (>90%)
than the other two methods. Less than 100 cells are detectable in the gelatin phantom
by both 3T and 7T MRI (Fig. 2 and Fig. 4). 7T data show almost double CNR compared
to corresponding sequence at 3T (Fig. 3). Using phase-cycled bSSFP at 7T, the CNRs
of AVE (6.00) and RMS (6.46) combined images are remarkably higher compared to SWI
(2.45)(Fig. 3). Among all combined phase cycled bSSFP images, RMS shows the highest
CNR with minimal banding (Fig. 3). Figure 4 shows the co-registered images of microscope
and MRI. With the same threshold of 40% signal decrease, 7T MRI can detect more
cells (51/63) than the 3T scanner (36/63). On pig brain, both
~100 and ~1000 cells can be detected with CNR of 5.17 in grey matter and 4.25 in white matter (Fig.
5).Discussion
Self-assembling nanocomplexes by combining ferumoxytol, heparin and
protamine (HFP)2 was a newly
introduced cell labeling strategy which was found to be the most efficient method
(>90%) in our study. Using combined phase-cycled bSSFP, less than 100 cells
are detectable in a gelatin phantom using both 3T and 7T clinical MRI scanners (Fig.
2 and 5), which is a significant improvement compared to previous results of
imaging minimal 1000 cells 2,4. SWI has been the
primary imaging method for SPIO labeled cells by taking advantage of the “blooming”
effect on MR phase images 5. Balanced SSFP offers
an appealing alternative to SWI for cell tracking using MRI 6,7, by taking advantage
of 1) the high SNR efficiency; 2) the unique T2/T1 contrast ideally suited for
detecting SPIOs that primarily generate negative T2-contrast with moderate
effects on T1; and 3) the strong intra-voxel magnetic gradients generated by a
SPIO labeled cell will cause multiple bands emanating from the cell 8.Conclusion
The proposed cellular
MRI with ferumoxytol nanocomplex labeled macrophages at 7T has improved
sensitivity to detect <100 cells. Since both ferumoxytol and 7T Terra are FDA approved
9, the proposed method
has great translational potential and may have potential clinical applications
in neoplasm, multiple sclerosis and Alzheimer’s disease.
Acknowledgements
This work was supported by National Institute of Health (NIH); contract
grant number: UH2-NS100614.References
1. Makela AV, Murrell DH, Parkins KM, Kara
J, Gaudet JM, Foster PJ. Cellular Imaging With MRI. Topics in Magnetic
Resonance Imaging 2016; 25(5): 177-86.
2. Thu MS, Bryant LH, Coppola T, et al.
Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine
for cell tracking by magnetic resonance imaging. Nature medicine 2012; 18(3):
463-7.
3. Klein S, Staring M, Murphy K, Viergever MA, Pluim JP. Elastix: a
toolbox for intensity-based medical image registration. IEEE transactions on
medical imaging 2010; 29(1): 196-205.
4. Shichinohe H, Kuroda S, Kudo K, et al.
Visualization of the superparamagnetic iron oxide (SPIO)-labeled bone marrow
stromal cells using a 3.0-T MRI—a pilot study for clinical testing of
neurotransplantation. Translational stroke research 2012; 3(1): 99-106.
5. Liu S, Buch S, Chen Y, et al.
Susceptibility-weighted imaging: current status and future directions. NMR
Biomed 2016.
6. Heyn C, Ronald JA, Mackenzie LT, et al.
In vivo magnetic resonance imaging of single cells in mouse brain with optical
validation. Magn Reson Med 2006; 55(1): 23-9.
7. Foster-Gareau P, Heyn C, Alejski A, Rutt
BK. Imaging single mammalian cells with a 1.5 T clinical MRI scanner. Magn
Reson Med 2003; 49(5): 968-71.
8. Heyn C, Bowen CV, Rutt BK, Foster PJ.
Detection threshold of single SPIO-labeled cells with FIESTA. Magn Reson Med
2005; 53(2): 312-20.
9. Hughes B. 2009 FDA drug approvals.
Nature Reviews Drug Discovery 2010; 9(2): 89-92.